一哥的业绩,投资人不买账

并购菁英汇
18 Nov 2024

以下文章来源于:瞪羚社, 作者:Kris.11月12日晚,百济神州发布了2024年三季报:公司在第三季度实现营业收入10.02亿美元,其中产品收入9.93亿美元(同比增长66.88%、环比增长7.87%),无论是泽布替尼还是替雷利珠单抗都实现高速的同比增长和稳健的环比增长。同时,公司第三季度净利润为2.15亿美元,主要由于与BMS-Celgene达成和解及终止协议带来的非现金收入3.63亿美元;经...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10